Apomorphine protects against MPTP-induced neurotoxicity in mice.
about
Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptorApomorphine treatment in Alzheimer mice promoting amyloid-β degradationDifferent susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1Apomorphine: an underutilized therapy for Parkinson's disease.Neuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?Dopamine receptors and Parkinson's diseaseMultifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.Multifunctional drugs with different CNS targets for neuropsychiatric disorders.Current approaches to the treatment of Parkinson's diseaseRedox imbalance in Parkinson's disease.Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive elementNeuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease.Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron.Apomorphine attenuates 6-hydroxydopamine-induced apoptotic cell death in SH-SY5Y cells.Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.Protection by apomorphine in two independent models of acute inhibition of oxidative metabolism in rodents.
P2860
Q24805917-F988C523-03B9-45D6-AA99-3115D68B8940Q28306851-03B28442-D371-49E5-BD60-66A3665340A3Q33646741-BCEC59EB-8131-40CC-881E-F27EAF509490Q34048141-5C9C3F21-7544-4FD2-B5CB-EB246331CD97Q34169019-ADA55B71-EA81-4A35-BCEF-545C171EBB54Q34217223-904879AB-1C40-4297-9432-DBEFB11DCD42Q35545020-C7C602FD-01A4-4F3E-A95F-62767121DE23Q36543057-2DC71DC2-AC3B-4C43-9B9F-C7352D0FAF99Q36630021-BA7C4C08-58D3-4EB6-B443-1C23B89CD453Q36876438-79F412C4-AF4A-430A-91D6-85E6B08D1ADAQ36899782-92899A91-CCD8-46A5-8189-CE2CC1285F19Q37166339-CB2681CB-4C32-47C5-8FAF-17D39CDCEFD0Q37418049-264A22A9-512B-44A2-88ED-19DECE896DACQ38074340-FD48D00F-DA29-4CE8-ADDD-9305FB618103Q38155589-99A74B2A-4BA4-4522-A038-E4E8AB89EDA7Q40592358-586D9DA9-8E28-415C-8420-7E8512DC574AQ40619926-59B77E45-C8C6-4116-A8E5-12335766FE81Q42164149-A824CA78-98D0-46A5-9E29-D888733E536AQ47868277-0DBBC12D-2925-4702-A519-AFE2079E68B2Q48474753-0ED8FA6E-328C-4DA9-AC0C-259C52260F38
P2860
Apomorphine protects against MPTP-induced neurotoxicity in mice.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Apomorphine protects against MPTP-induced neurotoxicity in mice.
@en
Apomorphine protects against MPTP-induced neurotoxicity in mice.
@nl
type
label
Apomorphine protects against MPTP-induced neurotoxicity in mice.
@en
Apomorphine protects against MPTP-induced neurotoxicity in mice.
@nl
prefLabel
Apomorphine protects against MPTP-induced neurotoxicity in mice.
@en
Apomorphine protects against MPTP-induced neurotoxicity in mice.
@nl
P2093
P2860
P1433
P1476
Apomorphine protects against MPTP-induced neurotoxicity in mice.
@en
P2093
P2860
P304
P356
10.1002/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6
P407
P577
1999-07-01T00:00:00Z